USNA  Usana Health Sciences Inc.

Exchange

NASDAQ

Sector

Consumer Durables

Industry

Specialty Chemicals

Market Cap.

1.301B

Vuru Grade

86.71/100

Current Price

$105.66
-1.34 (-1.25%)

Growth Price

$78.11
Overvalued by 26.07%

Stability Price

$127.53
Undervalued by 20.70%

Company Metrics

  • 19.96 P/E
  • 1.76 P/S
  • 6.64 P/B
  • 5.362 EPS
  • 54.96% Cash ROIC
  • 1.52 Cash Ratio
  • 0.00 / N/A % Dividend
  • 149,958.00 Avg. Vol.
  • 14.20M Shares
  • 1.301B Market Cap.

Company Description

USANA Health Sciences, Inc. develops, manufactures, distributes, and sells nutritional and personal care products worldwide. It offers two product lines, USANA Nutritionals and Sense. The USANA Nutritionals product line consists of essentials, which include vitamin and mineral supplements that provide a foundation of nutrition for various age groups; optimizers that are targeted supplements suppor...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Insider Trading Update: Take-Two Interactive Software , Usana Health Sciences ...
Markets Insider - 50 minutes ago
Usana Health Sciences Inc (NYSE:USNA): According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the Director of Usana Health Sciences Inc , Mcclain Jerry G had sold 759 shares worth of $89,562 in a ...
Usana Health Sciences Inc
MSN Money - Oct 11, 2014
USANA Health Sciences, Inc., was founded in 1992. The Company develops and manufactures high-quality, science-based nutritional and personal care products with a focus on promoting long-term health and reducing the risk of chronic ...
USANA Health Sciences, Inc. (USNA) Under Fire In China
ValueWalk - Jul 15, 2014
Citron Research out with its latest report, this time on USANA Health Sciences, Inc. (NYSE:USNA). This week multiple media outlets in China have exposed the MLM schemes operated by USANA Health Sciences, Inc. (NYSE:USNA) in China - a must read ...
USANA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP ... - Business Wire (press release)
USANA Down 5% After Short Seller, Greenberg Separately Offer Negative News - Benzinga
Pivotal Research Starts USANA Health Sciences Inc. (USNA) at Buy
StreetInsider.com (subscription) - Oct 20, 2014
Pivotal Research initiates coverage on USANA Health Sciences Inc. (NYSE: USNA) with a Buy rating and a price target of $100.00.
UPDATE: Pivotal Research Initiates Coverage On USANA Health Sciences
Benzinga - Oct 20, 2014
Pivotal Research Group initiated a Buy rating on USANA Health Sciences, Inc. (NYSE: USNA) with a $100 price target in a report issued Monday.
USANA Health Sciences Research Coverage Started at Pivotal Research (USNA) - Ticker Report
Stocks On the Move: Cliffs Natural Resources Inc, USANA Health Sciences, Inc ...
Schaeffers Research (blog) - Oct 29, 2014
Among specific names making notable moves, though, are mining magnate Cliffs Natural Resources Inc (NYSE:CLF), nutritional supplement specialist USANA Health Sciences, Inc. (NYSE:USNA), and cloud component concern Aerohive Networks Inc ...
Midday Gainers From October 29: USANA Health, Corporate Executive Board ... - Benzinga
USANA Health Sciences, Inc. (USNA) Issues FY14 Earnings Guidance - sleekmoney
Earnings Reaction History: USANA Health Sciences Inc., 33.3% Follow-Through ...
Nasdaq - Oct 28, 2014
is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement.
USANA Health Sciences, Inc. (USNA) Misses Q2 EPS by 14c
StreetInsider.com (subscription) - Jul 29, 2014
USANA Health Sciences, Inc. (NYSE: USNA) reported Q2 EPS of $1.36, $0.14 worse than the analyst estimate of $1.50. Revenue for the quarter came in at $188.3 million versus the consensus estimate of $198.3 million.
Investor Alert: USANA Health Sciences, Inc. (NYSE:USNA) under Investigation - GroundReport
New Vitamin D Research: Supplementation Is Best Way To Improve Vitamin D ... - PR Newswire (press release)
High Short Interest Alert:Usana Health Sciences Inc , Prosensa Holding B.V.
Markets Insider - Nov 25, 2014
Shares of Usana Health Sciences Inc (NYSE:USNA) are trading at $108.1. The price is 9% off the 52-week high and 49.1% off the 52-week low.
Harwood Feffer LLP Announces Investigation of USANA Health Sciences, Inc.
MarketWatch - Jul 17, 2014
NEW YORK, July 16, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against USANA Health Sciences, Inc. ("USANA" or the "Company") (NYSE: USNA) and its board of directors concerning whether the board has ...